Abstract
A new industrially viable synthesis of Montelukast, an anti‐asthmatic drug, is described.
Acknowledgment
The authors thank the management of Dr. Reddy's Laboratories Ltd., Bulk Actives Unit 1V, for supporting this work.
Notes
DRL Pub. No. IPDO‐IPM 00026.